IOVA:NASDAQ
Iovance Biotherapeutics Inc
$9.26
arrow_upward
+7.67%(+0.66) 1D
$9.24
arrow_downward
-0.17% (-0.016)todayPre-market
Closed: Sep 14, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IOVA...
Open
$8.56
High
$9.41
Low
$8.54
Mkt. cap
4.19B
Avg. vol.
17.02M
Volume
42.33K
52-wk high
$9.41
52-wk low
$1.76
EPS
-$0.72
Beta
0.83
Shares outstanding
452.97M
No. of employees
975
Open
$8.56
High
$9.41
Low
$8.54
Mkt. cap
4.19B
Avg. vol.
17.02M
Volume
42.33K
52-wk high
$9.41
52-wk low
$1.76
EPS
-$0.72
Beta
0.83
Shares outstanding
452.97M
No. of employees
975
News stories
From web sources and news partners
RTTNews
·
4 hours ago
Biotech Stocks At 52-Week Highs - NUTX +8%, IOVA +7%, ATRC, CNC, CON
Yahoo Finance
·
8 hours ago
SLS, IBRX, IOVA In Focus Amid Big Pharma’s Early Cancer-Asset Hunt: J&J Flags M&A ‘Sweet Spot,’ Pfizer Eyes Phase 1-2 Deals
Stocktwits
·
15 hours ago
SLS, IBRX, IOVA Catch The Spotlight As J&J, Pfizer Hunt Early-Stage Cancer Deals
Investing.com
·
18 hours ago
Iovance Biotherapeutics stock hits 52-week high at 9.36 USD
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteiovance.com